Nautilus Biotechnolgy Inc. (NASDAQ: NAUT)
$1.7800
+0.1100 ( +4.09% ) 38.2K
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. It has built a prototype of a single-molecule instrument, Proteomic Analysis System.
Market Data
Open
$1.7800
Previous close
$1.6700
Volume
38.2K
Market cap
$219.74M
Day range
$1.6870 - $1.8150
52 week range
$1.6100 - $3.2500
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Jun 17, 2024 |
| 4 | Insider transactions | 1 | Jun 17, 2024 |
| 4 | Insider transactions | 1 | Jun 17, 2024 |
| 4 | Insider transactions | 1 | Jun 17, 2024 |
| 4 | Insider transactions | 1 | Jun 17, 2024 |
| 4 | Insider transactions | 1 | Jun 17, 2024 |
| 8-k | 8K-related | 13 | Jun 13, 2024 |
| 8-k | 8K-related | 14 | Apr 30, 2024 |
| 10-q | Quarterly Reports | 63 | Apr 30, 2024 |
| ars | Annual reports | 1 | Apr 26, 2024 |